Recently added articles from Clinical Psychiatry News:
Mitochondria key in mood disorders.
Oct 01, 2009; ... SANTA FE, N.M.--Mitochondrial dysfunction plays a role in recurring mood disorders, and might help explain why most treated patients eventually have relapses or recurrences, according to a leading investigator in psychiatry and pharmacology. Unipolar and bipolar disorder are not ...
Stimulants fend off comorbidities in boys with ADHD: treated patients less likely to repeat grade.(Clinical report)
Oct 01, 2009; ... ISTANBUL, TURKEY--Stimulant therapy for boys with attention-deficit/hyperactivity disorder protected them into young adulthood against development of depression, anxiety disorders, and disruptive behavior disorders in a landmark 10-year prospective case-control study. Perhaps ...
Methamphetamine use in U.S. continues slide.
Oct 01, 2009; ... WASHINGTON--The past-month methamphetamine use dipped sharply from 529,000 in 2007 to 314,000 in 2008 in people aged 12 years and older, according to data from the 2008 National Survey on Drug Use and Health. That represents a decline of past-month meth use by almost half since ...
AACAP offers guide on psychotropics for children.
Oct 01, 2009; ... Although strides have been made in use of psychotropic medications in children and adolescents, concerns remain over whether these medications are always being prescribed appropriately. That's one reason that the American Academy of Child & Adolescent Psychiatry gives for ...
Top 10 corporations by dispensed prescriptions, 2008 (total Rx in millions).(VITAL SIGNS)(Company rankings)
Oct 01, 2009 ... <Pre> Teva Pharmaceuticals USA 494.2 Mylan 307.7 Novartis 250.2 Watson Pharmaceuticals223.3 Pfizer215.1 Barr Laboratories ...